By Denise L. Faustman, et al. DOI:https://doi.org/10.1016/j.xcrm.2022.100728 Highlights •We report on our randomized trial of multi-dose BCG for protection against COVID-19•BCG is safe and has 92% efficacy versus placebo against COVID-19•Findings also suggest platform...
Multiple BCG vaccinations for prevention of COVID-19 and other infectious diseases in Type 1 diabetes
read more